Therefore, the identification of APOB mutations in subjects with NAFLD-HCC would be to allow the diagnosis, in these cases mostly unrecognized, of familial hypobetalipoproteinemia in the first-degree relatives, allowing to establish adequate HCC surveillance. The gene discussed is APOB; the disease is hypobetalipoproteinemia.